Rheumatoid Arthritis Recruiting Phase Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01197144Pain Modulation in Rheumatoid Arthritis (RA) - Influence of AdalimumabBasic Science
NCT01965132Korean College of Rheumatology Biologics Registry
NCT03016260RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
NCT02778789Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers
NCT02620189Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα
NCT04089514A Real-world Study of Imraldi® Use